JAKARTA - PT Siloam International Hospitals Tbk scored a significant performance growth in the first six months of this year. The revenue and profit of this SILO stock-coded hospital company was able to soar in the first semester of 2021.

Based on Siloam's unaudited financial report as of June 30, 2021, quoted on Thursday, August 26, the company from the Lippo group belonging to the conglomerate Mochtar Riady scored revenue of IDR 3.81 trillion during the first 6 months of 2021, an increase of 51.65 percent compared to the same period last year, which amounted to IDR 2.51 trillion.

The cost of revenue also increased to IDR 2.02 trillion, up from IDR 1.55 trillion in the same period last year. Operating expenses also increased to IDR 1.15 trillion from IDR 905.22 billion.

Despite the increase in expenses, the company's operating profit was recorded to be able to grow significantly to IDR 493.81 billion from the first half of last year, which was only IDR 4.93 billion. As a result, Siloam Hospitals recorded a profit for the period attributable to owners of the parent entity to IDR 291.53 billion.

This achievement reversed from a loss position of IDR 130.04 billion in the first half of 2020. Siloam President Director Darjoto Setyawan stated that Siloam was able to play an important role in helping Indonesia fight COVID-19.

"We have performed more than 160.000 public vaccinations so far in 2021. Siloam has performed nearly 500.000 PCR tests and more than 2.6 million rapid and serological tests. We have treated more than 24.000 COVID-19 patients", he said.

Siloam manages and operates 39 hospitals in Indonesia. In detail, 14 hospitals in the Greater Jakarta area and 25 hospitals spread across other areas of Java, Sumatra, Kalimantan, Sulawesi, Bali, and Nusa Tenggara.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)